Biocon appoints Rajesh Umakant Shanoy as Company Secretary, Compliance Officer

Published On 2025-09-10 09:10 GMT   |   Update On 2025-09-10 09:10 GMT
Advertisement

Bangalore: Biocon has announced the appointment of Rajesh Umakant Shanoy as the Company Secretary and Compliance Officer of the company.

This follows the cessation of Ekta Agarwal as the Interim Company Secretary and Compliance Officer of the Company with effect from close of business hours of September 09, 2025.

"We would like to inform you that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors at its meeting held on September 09, 2025 has approved appointment of Rajesh Umakant Shanoy (ICSI Membership No.: ACS 16328), as the Company Secretary and Compliance Officer (being Key Managerial Personnel) of the Company with effect from September 10, 2025 pursuant to the provisions of Regulation 6 of SEBI Listing Regulations and Section 203 of the Companies Act, 2013," Biocon stated in a BSE filing.

Advertisement
Rajesh Umakant Shanoy is a qualified Company Secretary, Cost Accountant and CIMA (Strategic level) (UK), with overall more than 24 years of rich experience in corporate secretarial, legal, financial, and cost and management accounting functions across sectors, including manufacturing, chemicals, media and financial services.
Prior to joining Biocon, he was working with Bajaj group since Dec 2011, including overseeing compliance of the Companies Act, SEBI and allied laws for Bajaj Finance Limited and its two subsidiaries.
From April 2017, he headed the Corporate Secretarial function of Bajaj Allianz Life Insurance Company Limited. Prior to this, he has worked with leading organizations, including Akzo Nobel Chemicals India Limited, Deepak Fertilisers and Indiacom Limited.

Biocon Limited, publicly listed in 2004, is a global biopharmaceutical company. It has developed and commercialized novel biologics, biosimilars and complex small molecule APIs in India and several key global markets, as well as generic formulations in the US and Europe.

Read also: Biocon Biologics appoints Deepali Naair as Global Head - Brand & Corporate Communications

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News